??????? Part 20 of 49 - Video Presentations of the "1st Conference on Integrating Early Detection of Heart and Lung Disease through Low-Dose CT": Day 1 Session 3: Panel Discussions. Experts discuss advanced imaging and AI in early disease detection, emphasizing standardized reporting and insurance for preventive measures. https://wix.to/h4WrrYe Hosted by the International Early Lung Cancer Action Program (I-ELCAP). We want to thank our distinguished speakers, including Dr. Samuel M. Aguayo, MD, Dr. Nasser Altorki, MD, Dr. Amir Ahmadi, MD, Ricardo Avila, MS, Dr. Mary Beth Beasley, MD, Vickie Beckler, MBA, RN, Peter Bernholt, Dr. Andrea Branch, PhD, Dr. Matthew Cham, MD, Dr. Joelle Thirsk Fathi DNP, RN, ARNP, CTTS, FAANP, FAAN, Dr. Zahi Fayad, Dr. raja flores MD, Dr. Susan K. Fried, Dr. Valentin Fuster, MD, PhD, Dr. Elizabeth Garner, MD, MPH, Dr. Ilya Gipp MD, PhD, Dr. Yongfeng Gao, PhD, Dr. Lee Goldsmith, MD, Dr. Frederic Grannis Jr, MD, Catharine Grimes, MBA, Dr. Louis Gros, MD, Dr. Timothy Harkin, MD, Dr. Robert A. Harrington MD, Dr. Sebron Harrison, MD, Dr. Rob Headrick MD MBA, Cheryl Healton, DrPH, Dr. Claudia Henschke, PhD, MD, Dr. Fred Hirsch, MD, PhD, Dr. Mingqian Huang, MD, Dr. Ella A. Kazerooni, MD, MS, Dr. Karen Kelly, MD, Dr. Paul Lee, MD, Dr. David Maron, MD, Dr. Steven Markowitz, MD, DrPH, Dr. Glenn Martin, MD, Dr. Michael V. McConnell, MD, MSEE, Anita McGlothlin, Dr. Jeffrey Mechanick, MD, Dr. Roxana Mehran, MD, Dr. Mark Metersky, MD, Dr. Jim Mulshine, MD, Dr. Morteza Naghavi, M.D., Dr. Jagat Narula MD PhD, Dr. Khurram Nasir, MD MPH MSc, Dr. Maria Padilla, MD, Dr. Sean Pinney, MD, Dr. Bruce Pyenson, FSA, MAAA, Juan Carlos Ramirez-Giraldo, PhD, Dr. Jamal Rana MD FACC, Dr. Vivek Reddy, MD, Anthony Reeves, PhD, Dr. Albert Rizzo, MD, Lori Sakoda, PhD, MPH, Dr. Robert Samstein, MD, PhD, Dr. Victoria Schneider, MD, Dr. Dorith Shaham, MD, Dr. Samin K. Sharma, MD, Dr. Joseph Shemesh, MD, Dr. Samir Shah, MD, Robert Smith, PhD, Dr. Rozemarijn Vliegenthart, MD, PhD, Dr. Andrea Wolf, MD, MPH, Dr. Nathan Wong, MD, PhD, Dr. David Yankelevitz, MD, Dr. Rowena Yip, PhD, MPH, Chenyu Zhang, MS, Dr. Javier J Z., MD, and many more world leaders in cardiovascular disease and lung cancer screening for making the 1st Conference on Integrating Early Detection of Heart and Lung Disease through Low-Dose CT possible. Special thanks to our sponsors GE HealthCare led by Roland Dias, Ilya Gipp MD, PhD, Siemens Healthineer led by Sebastian Schmidt, and other leading medical companies in CT imaging and AI. #CardioTwitter #AutoChamber #AICVD #AICAC #CCTA #CAC #CACscan #CACscore #calciumscore #calcium_score #coronary_calcium_score #coronary_calcium #CAC_scan #CAC_score #HeartFlow #Cleerlyhealth #Cardiology #AIinHealthcare #heartfailure #Afib #FDAbreakthrough #heartdisease #heartdiseaseprevention #lungcancer #lungcancerprevention #LDCTscreening #LDCT_screening #shapesociety SHAPE Society (Society for Heart Attack Prevention and Eradication)
HeartLung.AI的动态
最相关的动态
-
There is a need for targeted, fast and reliable diagnostics at the point of patient care to identify curable precancerous disease stages that enable timely treatment and better patient outcomes for patients with gastric cancer. Dr. Cinzia Papadia MD FRCP, a Consultant Gastroenterologist at Barts Health NHS Trust and Honorary Senior Lecturer at Queen Mary University of London, discusses the use of a first-line case selection tool for gastric cancer risk.
-
?? #OneLife, #OneLiver Join ELPA (European Liver Patients' Association) at #UEGWeek2024 and be part of our mission to elevate the voice of liver patients across Europe! This October, during #LiverCancerAwarenessMonth, there's no better time to engage with our work and learn how we’re driving progress in liver health. At our booth, you’ll discover how ELPA is tackling one of the most serious health challenges of our time—liver cancer—and how we advocate for improved prevention, diagnosis, and treatment. Here’s what you can learn at our booth: 1. Liver Cancer Awareness & Advocacy:** Discover our special focus on liver cancer and Liver Health this month, and how we are raising awareness about the importance of early detection, better screening, and accessible treatments to save lives. Learn about our ongoing efforts to shape policy and increase public understanding of the disease. 2. Patient Empowerment: ELPA empowers liver cancer patients by providing resources, support, and a platform for their voices to be heard. We ensure that patients play a central role in decision-making processes related to their care and treatment. 3. Prevention Campaigns: Understand how our awareness campaigns target key risk factors of liver cancer ( #obesity, #MASLD, #MASH, #Hepatitis, #alcohol, #RareLiverDiseases), and how we promote prevention strategies that can significantly reduce #livercancer rates. 4. Collaboration for Change: Learn about our collaborations with healthcare professionals, researchers, and policymakers across Europe. By bringing all stakeholders together, ELPA ensures that the fight against liver cancer remains a top priority on the European health agenda. 5.Research & Innovation: Explore the latest breakthroughs in liver cancer research and how ELPA is contributing to shaping research priorities that focus on patient needs. 6. #LiverCancerAwarenessMonth Initiatives: Be part of our October awareness activities and discover how you can contribute to raising awareness of #livercancer. Whether you’re a healthcare professional, policymaker, patient, or supporter, your voice matters. October is a crucial time to focus on liver cancer and Liver Health, and by visiting the ELPA booth, you’ll gain valuable insights into how we’re leading the way in transforming liver healthcare. Let’s work together to make liver cancer and Liver diseases prevention and treatment more effective and accessible for all. See you at #UEGWeek2024! UEG - United European Gastroenterology ?? ?? ?? European Commission European Health and Digital Executive Agency (HaDEA) WHO Regional Office for Europe EU Health and Food Safety ESMO - European Society for Medical Oncology International Liver Cancer Association (ILCA) EASL the home of Hepatology Aleksander Krag Manuel Romero Gomez European Cancer Organisation Cancer Patients Europe - CPE European Patients' Forum European Public Health Alliance (EPHA) Marko Korenjak MSc Milan Mishkovikj, M.A. Beatrice Credi Shaibu Issa
-
-
Watch Jacqueline's compelling story about her diagnosis with Neuroendocrine Cancer (NET) in our latest video in the Community Compass Campaign in partnership with Ipsen.? At 62, her diagnosis sparked crucial reflections on work-life balance. Discover how Jacqueline navigated the challenges of NET symptoms, from heart palpitations to breathlessness, often mistaken for other conditions.? ?Her 7-year journey from symptoms to diagnosis sheds light on the complexity of this disease. Gain insights into the critical role of early detection through a doctor-ordered scan, uncovering a hidden tumour in Jacqueline's abdomen. Education became their power as Jacqueline and Meg dove into understanding the diagnosis, making informed decisions.? Meg emphasises the importance of patient education during stressful times. "What Jacq did really well was to educate herself, understand prognosis, and explore treatment options. This empowered open conversations."? Join us in promoting awareness, education, and patient support. Watch the video to enhance your understanding of NET and empower patient care.? Watch the full video here: https://lnkd.in/gCNfB24V *In partnership with Ipsen, NeuroEndocrine Cancer Australia (NECA) presents the ‘Community Compass Campaign’, a disease awareness initiative empowering patients with neuroendocrine tumours (NETs) to navigate how they live with their condition through the shared experience of other people living with NETs.?
-
Artificial intelligence (AI) is making waves in medical research, unlocking new possibilities for detecting deadly diseases early and efficiently. From pinpointing rare cancers to streamlining infection diagnosis, AI is proving to be a game-changer in healthcare innovation. In a recent report by the?BBC, it was outlined that ovarian cancer is often called “rare, underfunded, and deadly,” according to Audra Moran, head of the Ovarian Cancer Research Alliance (Ocra), as she explained to?Pádraig Belton, BBC reporter. Detecting it early is critical, but challenging according to the news outlet. Most cases begin in the fallopian tubes, and by the time symptoms appear, the cancer may have already spread.
-
Associate Professor of Medicine, Section of Geriatrics and Palliative Medicine
I'm thrilled to share our latest publication:?"Systemic and Procedural Challenges in Transitioning Patients with Cancer to Post-Acute and Long-Term Care Facilities: A Prospective Mixed-Methods Study"? Co-authored with?Oisharya?Dasgupta,?Dr. Nabiel Mir,?Kunal?Desai, and explores critical gaps in care transitions for cancer patients moving from acute care to PALTC facilities. Our study highlights: ??Medication reconciliation and appointment challenges ?? Barriers like?poor communication &?documentation challenges ?? Opportunities to improve outcomes through tailored interventions like better EHR integration, structured transfer protocols, and enhanced communication pathways With the growing complexities in cancer care, these findings emphasize the urgent need for systemic reforms to enhance transitions and support this vulnerable population.Post-Acute and Long-Term Care Medical Association (PALTmed) ???Read the full study:?https://lnkd.in/g-gdD-QC Let's advance the conversation on improving cancer care transitions! #CancerCare #CareTransitions #Oncology #PostAcuteCare #GeriatricOncology
-
https://lnkd.in/e56UHTCs Article title: Virtual ward: The future in the management of neutropenic sepsis in the NHS Author(s):?Taiwo DD; Nnamani N; Ochai A; Adeyinka OO Journal: Innovations in Cancer Science & Clinical Therapeutics Abstract: Virtual ward offers patients with neutropenic sepsis a unique opportunity to receive hospital level of care in the comfort of their home, especially for patients who would otherwise be admitted to hospital because of their acute treatment. On the virtual ward, patients can receive hospital level of care with a significant opportunity to mitigate any risk of hospital-acquired infection in this subset of patients who are already immunocompromised amongst other benefits. Additionally, hospital length of stay can be shortened leading to reduced admission pressure in hospitals, increasing hospital admission avoidance, and encouraging safe discharge from hospital while still providing the best care for the patients. We report a case of a 76-year-old cancer patient who presented with neutropenic sepsis and was successfully managed on the virtual ward in a district hospital. This case highlights the importance of virtual wards an evolving innovation that can define the future management of cancer patients in NHS. It is safe and reduces the cost of inpatient care in healthcare. #Virtualward #Neutropenicsepsis #Hospitallevelofcare #Remotemonitoring #Chemotherapy #NHS ? #CancerBiology #CancerGenetics #CancerImmunology #CancerStemCells #CancerDiagnosisAndScreening #BiomarkersInCancerDiagnosisAndTreatment #Peertechz #PeertechzPublications #PrecisionMedicineInCancerTreatment #CancerDrugDiscoveryAndDevelopment #ChemotherapyAndOtherSystemicTreatments #RadiotherapyAndOtherLocalTreatments #ImmunotherapyAndOtherTargetedTreatments #SurgeryAndOtherLocalTreatments #PalliativeCareAndSymptomManagement #CancerSurvivorshipAndQualityOfLife #CancerEpidemiologyAndPrevention #CancerDisparitiesAndHealthEquity #ClinicalTrialsInCancerResearch #TranslationalResearchInCancerScience #BigDataAndArtificialIntelligenceInCancerResearch #EthicsAndPolicyInCancerResearchAndCare #AngiogenesisInhibitors #Apoptosis #Biomarkers #Biopharmaceuticals #CancerBiology #CancerDiagnosis #CancerDrugDiscovery #CancerGenetics #CancerImmunology #CancerPrevention #CancerStemCells #Chemoprevention #Chemotherapy #ClinicalTrials #CompanionDiagnostics #ComputationalModeling #Epigenetics #GeneTherapy #Genomics #Immunotherapy #Inflammation #LiquidBiopsy
-
-
Individualized Medicine: Addressing Health Disparities in Colorectal Cancer Treatment Description: While Minnesota has returned to its status as a top-ranking healthcare state in the U.S. (Carbajal, E., 2024) health disparities remain prevalent among underserved populations. This initiative seeks to close these gaps by focusing on personalized care and advancing equity in colorectal cancer prevention. Developing personalized treatment plans for colorectal cancer patients presents unique challenges, particularly in addressing health disparities that disproportionately affect minority and underprivileged groups. Minnesota’s growing demographic diversity and evolving disease trends highlight the need for more targeted healthcare strategies. The CDC’s 2013 Health Disparities and Inequalities Report (Meyer, P.A., 2013) emphasized the need for advancing health equity for all populations. Aligned with the NIH's focus on minority health disparities, this project seeks to develop a comprehensive bio-psycho-social and clinical algorithm. By analyzing retrospective clinical and epidemiological data, the aim is to improve colorectal cancer prevention and enhance survival outcomes for minority patients treated in hospitals across Minnesota. Ref: Carbajal, E., 2024 https://lnkd.in/gaMiBptG? Meyer, P.A., P.W. Yoon, and R.B. Kaufmann, Introduction: CDC Health Disparities and Inequalities Report - United States, 2013. Morbidity and mortality weekly report. Surveillance
-
Striving for Human-Centered Health Care | Medical Director Intermountain Health
My GI colleague and friend, Dr. Mike Smith, did a great job presenting our collective colorectal cancer (CRC) screening data analysis work across health systems and sites with this poster presentation at the American College of Gastroenterology 2024 Annual Meeting. ?? We ALL need to continue to encourage patients, family, friends, colleagues to get screened for colon cancer starting at age 45 and potentially earlier if there is a significant family history of colon cancer and/or pre-cancerous colon polyps. ?? Here is the summary of the findings: “There is a staggering increase in the number of high risk lesions detected during CRC screening colonoscopy over the study period for both cohorts, 59% for ages 50-54 and 44% for ages 45-49. By 2023, high risk lesion detection in the age 45-49 cohort reached the same rate the age 50-54 cohort had less than a decade before. These findings, plus a similar polyp detection rate in both groups, demonstrate the benefit of initiating CRC screening at ages 45-49 as high risk lesion detection rates continue to rise.” #GetScreenedForColonCancer #45isthenew50
-
It is because of early detection, and the dedication of scientists, researchers, doctors, nurses, and patients that at 83-years-old, my mother is still here with us today as a two-time breast cancer survivor.?? ? A recent article in STAT highlights a paper from JAMA Network Open, indicating that while cancer diagnoses returned to pre-COVID-19 levels in 2021, an estimated 130,000 cancer cases likely went undiagnosed in 2020. Although COVID-19 was a unique period in healthcare and some of these cases may have been detected later, this underscores the importance of understanding your family’s medical history, attending regular screenings like mammograms and colonoscopies, and prioritizing routine visits to your primary care physician to maintain optimal health.? ? It is critical that we continue to support the research, scientific advancements, and community of cancer survivors enabling us to enhance early detection, diagnosis, and successful treatment. Additionally, it is crucial to address health equity by expanding access to early cancer detection through community outreach and education programs, and by increasing opportunities for screenings and services in underserved areas.? ? Together, we can drive change in the fight against cancer. By prioritizing early detection and equitable access to healthcare, we can build a healthier future for everyone.? #cancerscreening #BMS_employee https://lnkd.in/gySKeYuv
-
*?? Invitation to Attend the International Medical Workshop: "Prostate Cancer: Diagnosis, Prevention, and Medical Care" ??* ?? *Date:* January 2, 2025 ?? *Time:* 8:00 PM ???? *Platform:* Center's Platform | Google Meet Link: [https://lnkd.in/e2WPtf6M) Did you know that prostate cancer is the second most common cancer among men? But did you also know that early diagnosis and following effective prevention methods can completely change the outcome? *In this unique workshop, we will delve into everything related to:* - *Early diagnosis:* New techniques that allow us to detect the disease in its early stages. - *Prevention strategies:* What can we do to protect ourselves? Prevention is better than treatment. - *Treatment and medical care:* The latest medical protocols that help improve the quality of life for patients. *?? Why should you attend?* - *Direct interaction with experts* in the field of prostate cancer. - *Exclusive information* on the latest developments in prevention, diagnosis, and treatment. - *Opportunity to network* with specialists and professionals in the healthcare field. ??? This is your chance to be at the heart of the event, where we discuss the latest scientific advancements in combating prostate cancer. Don’t miss this distinguished scientific event! *?? January 2, 2025 | 8:00 PM* *?? Don’t wait, take a step toward health awareness and begin your journey to a deeper understanding of the disease.*
